Supplemental material
OncoImmunology
Volume 1, 2012 - Issue 7
Open access
1,491
Views
44
CrossRef citations to date
0
Altmetric
Original Research
Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance
Tatsuaki Mizutani Ludwig Boltzmann Institute for Cancer Research; Vienna, Austria
, Nina Neugebauer Institute of Pharmacology; Medical University of Vienna; Austria
, Eva M. Putz Institute of Pharmacology and Toxicology; University of Veterinary Medicine Vienna; Vienna, Austria
, Nadine Moritz Institute of Pharmacology; Medical University of Vienna; Austria
, Olivia Simma Institute of Pharmacology; Medical University of Vienna; Austria
, Eva Zebedin-Brandl Institute of Pharmacology; Medical University of Vienna; Austria
, Dagmar Gotthardt Institute of Pharmacology and Toxicology; University of Veterinary Medicine Vienna; Vienna, Austria
, Wolfgang Warsch Institute of Pharmacology and Toxicology; University of Veterinary Medicine Vienna; Vienna, Austria
, Eva Eckelhart Institute of Pharmacology; Medical University of Vienna; Austria
, Hans-Peter Kantner Ludwig Boltzmann Institute for Cancer Research; Vienna, Austria
, Ulrich Kalinke Institute for Experimental Infection Research; TWINCORE; Centre for Experimental and Clinical Infection Research; A joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School; Hannover, Germany
, Stefan Lienenklaus Molecular Immunology; Helmholtz Centre for Infection Research; Braunschweig, Germany
, Siegfried Weiss Molecular Immunology; Helmholtz Centre for Infection Research; Braunschweig, Germany
, Birgit Strobl Biomodels Austria, Institute of Animal Breeding and Genetics; University of Veterinary Medicine; Vienna, Austria
, Mathias Müller Biomodels Austria, Institute of Animal Breeding and Genetics; University of Veterinary Medicine; Vienna, Austria
, Veronika Sexl Institute of Pharmacology and Toxicology; University of Veterinary Medicine Vienna; Vienna, Austria
& Dagmar Stoiber Ludwig Boltzmann Institute for Cancer Research; Vienna, Austria; Institute of Pharmacology; Medical University of Vienna; AustriaCorrespondence[email protected]
show all
Pages 1027-1037
|
Received 29 Mar 2012, Accepted 27 Jun 2012, Published online: 01 Oct 2012
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.